Large-Fiber Dysfunction in Diabetic Peripheral Neuropathy Is Predicted by Cardiovascular Risk Factors
- Jackie Elliott, PHD1,
- Solomon Tesfaye, FRCP1,
- Nish Chaturvedi, MRCP2,
- Rajiv A. Gandhi, MRCP1,
- Lynda K. Stevens, MSC3,
- Celia Emery, PHD1,
- John H. Fuller, FRCP3 and
- on behalf of the EURODIAB Prospective Complications Study Group*
- 1Diabetes Research Unit, Royal Hallamshire Hospital, Sheffield, U.K.;
- 2National Heart and Lung Institute, Imperial College at St. Mary's, London, U.K.;
- 3Department of Epidemiology and Public Health, Imperial College of Science, Technology and Medicine, London, U.K.
- Corresponding author: Jackie Elliott, jackie.elliott{at}sth.nhs.uk.
Abstract
OBJECTIVE Diabetic large–nerve fiber dysfunction, as measured by vibration perception threshold (VPT), predicts foot ulceration, amputation, and mortality. Thus, determination of modifiable risk factors is of great clinical importance.
RESEARCH DESIGN AND METHODS We assessed 1,407 patients with type 1 diabetes and a normal VPT participating in the EURODIAB Prospective Complications Study, at baseline mean ± SD age of 32.7 ± 10.2 years with diabetes duration of 14.7 ± 9.3 years and follow-up of 7.3 ± 0.6 years. VPT was measured using biothesiometry on the right big toe and medial malleolus. An abnormal result was defined as >2 SD from the predicted mean for the patient s age.
RESULTS An abnormal VPT was associated with an increased incidence of gangrene, amputation, foot ulceration, leg bypass or angioplasty, and mortality (P ≤ 0.02). The incidence of abnormal VPT was 24% over the 7.3-year follow-up. Duration of diabetes and A1C significantly influenced the incidence of abnormal VPT (P < 0.0001). After correction for these, established risk factors for cardiovascular disease (CVD), including male sex (P = 0.0004), hypertension (P < 0.0001), total cholesterol (P = 0.002), LDL cholesterol (P = 0.01), smoking (P < 0.0001), weight (P < 0.0001), and diabetes complications (retinopathy [P = 0.0001], nephropathy [P = 0.01], and autonomic neuropathy [P = 0.001]), were all found to be significant risk factors. A previous history of CVD doubled the incidence of abnormal VPT.
CONCLUSIONS This prospective study indicates that cardiovascular risk factors predict development of large-fiber dysfunction, which may account for the high mortality rate in patients with an abnormal VPT, and emphasizes the importance of early determination of VPT to detect subclinical neuropathy and to address cardiovascular risk factors.
Footnotes
-
↵*A complete list of the EURODIAB Prospective Complications Study Group investigators can be found in the online appendix at http://care.diabetesjournals.org/cgi/content/full/dc09-0554/DC1.
-
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Received March 27, 2009.
- Accepted June 30, 2009.
- © 2009 by the American Diabetes Association.














